NEA Management Company, LLC
Filing Date
Global Rank
#1,512
/ 8,700
▲ 303
Top Industry
Biotechnology
94.8%
Period ended 2 months ago
Filed Aug 14, 2026 · 30d
26 quarters · since Mar 2020
Portfolio Concentration
26 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
15.5%
−3.0 pts
Top 5
61.4%
−0.3 pts
Top 10
89.8%
+1.7 pts
HHI
968
Diversified−25
Portfolio Trend
26 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 95.4% | $1,515,363,227 |
| Consumer Defensive | 4.6% | $72,574,217 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
New Positions
Positions the filer opened this quarter
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc. | 576,780 | $5,635,140 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| — | 3,045,262 | $0 | ||
| No positions match the current search. | ||||
26 tracked positions ·
$1,587,937,444 total
· filing declares
26 positions · $1,587,937,058
· as of Jun 30, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| TRVI |
Trevi Therapeutics, Inc.
Healthcare
|
Held | 13,222,228 | $246,594,552 | 15.53% | |
| MBX |
MBX Biosciences, Inc.
Healthcare
|
Held | 3,614,486 | $199,519,627 | 12.56% | |
| GLUE |
Monte Rosa Therapeutics, Inc.
Healthcare
|
Held | 7,692,298 | $186,153,611 | 11.72% | |
| CELC |
Celcuity Inc.
Healthcare
|
Reduced | 1,710,561 | $178,958,891 | 11.27% | |
| SGP |
SpyGlass Pharma, Inc.
Healthcare
|
Held | 7,392,301 | $164,552,620 | 10.36% | |
| SVRA |
Savara Inc
Healthcare
|
Held | 24,471,264 | $150,742,986 | 9.49% | |
| ZBIO |
Zenas BioPharma, Inc.
Healthcare
|
Held | 4,023,219 | $102,109,298 | 6.43% | |
| COUR |
Coursera, Inc.
Consumer Defensive
|
Held | 12,867,769 | $72,574,217 | 4.57% | |
| AUPH |
Aurinia Pharmaceuticals Inc.
Healthcare
|
Held | 3,969,834 | $67,368,082 | 4.24% | |
| CRSP |
CRISPR Therapeutics AG
Healthcare
|
Held | 1,058,570 | $57,734,407 | 3.64% | |
| ORIC |
Oric Pharmaceuticals, Inc.
Healthcare
|
Held | 4,118,621 | $44,604,665 | 2.81% | |
| PHAT |
Phathom Pharmaceuticals, Inc.
Healthcare
|
Held | 1,960,169 | $21,267,833 | 1.34% | |
| KRRO |
Korro Bio, Inc.
Healthcare
|
Held | 1,297,893 | $17,106,229 | 1.08% | |
| XFOR |
X4 Pharmaceuticals, Inc
Healthcare
|
Held | 3,233,743 | $15,101,579 | 0.95% | |
| CSBR |
Champions Oncology, Inc.
Healthcare
|
Held | 1,713,720 | $10,556,515 | 0.66% | |
| NKTX |
Nkarta, Inc.
Healthcare
|
Held | 3,568,781 | $10,099,650 | 0.64% | |
| CVRX |
CVRx, Inc.
Healthcare
|
Reduced | 1,954,440 | $10,045,821 | 0.63% | |
| BDTX |
Black Diamond Therapeutics, Inc.
Healthcare
|
Held | 4,448,757 | $8,230,200 | 0.52% | |
| KPTI |
Karyopharm Therapeutics Inc.
Healthcare
|
NEW | 576,780 | $5,635,140 | 0.35% | |
| IVA |
Inventiva S.A.
Healthcare
|
Held | 1,462,586 | $5,528,575 | 0.35% | |
| LONA |
LeonaBio, Inc.
Healthcare
|
Held | 464,398 | $4,267,817 | 0.27% | |
| SNTI |
Senti Biosciences Holdings, Inc.
Healthcare
|
Held | 3,775,615 | $4,153,176 | 0.26% | |
| MRKR |
Marker Therapeutics, Inc.
Healthcare
|
Held | 1,625,678 | $2,389,746 | 0.15% | |
| OKUR |
OnKure Therapeutics, Inc.
Healthcare
|
Held | 478,548 | $2,182,178 | 0.14% | |
| IMA |
ImageneBio, Inc.
Healthcare
|
Held | 50,005 | $295,029 | 0.02% | |
| GOSS |
Gossamer Bio, Inc.
Healthcare
|
Held | 1,000,000 | $165,000 | 0.01% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.